Literature DB >> 22781846

Catheter-assisted 18F-FDG-PET/CT imaging of primary bladder cancer: a prospective study.

Laura S Mertens1, Natascha M Bruin, Erik Vegt, Willem M de Blok, Annemarie Fioole-Bruining, Bas W van Rhijn, Simon Horenblas, Wouter V Vogel.   

Abstract

OBJECTIVE: The purpose of this study was to prospectively investigate the value of a standardized 18F-fluorodeoxyglucose (18F-FDG)-PET/computed tomography (CT) protocol for imaging of primary bladder cancer, using standardized bladder flushing and filling.
METHODS: We included 19 patients with cT1-4 bladder cancer. A Foley catheter was inserted before 18F-FDG injection. PET/CT imaging was performed according to four bladder protocols: (1) bladder empty; (2) bladder empty after flushing; (3) bladder filled with 50 ml saline; and (4) bladder filled with 100 ml saline. Tumour visibility was assessed and compared with histopathology or CT and cystoscopy.
RESULTS: The procedure was successfully completed in 16 out of 19 patients. The reference standard revealed a bladder tumour in 16 out of 19 patients. Sensitivity of protocols 1 and 2 was 0.38 [95% confidence interval (CI), 0.16-0.64] compared with 0.63 (95% CI, 0.36-0.84) for protocols 3 and 4.
CONCLUSION: Flushing and subsequent retrograde filling of the bladder results in the highest rate of tumour visualization and quantification. Flushing alone is inferior.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22781846     DOI: 10.1097/MNM.0b013e3283567473

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  7 in total

1.  Improving bladder cancer imaging using 3-T functional dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Huyen T Nguyen; Kamal S Pohar; Guang Jia; Zarine K Shah; Amir Mortazavi; Debra L Zynger; Lai Wei; Daniel Clark; Xiangyu Yang; Michael V Knopp
Journal:  Invest Radiol       Date:  2014-06       Impact factor: 6.016

Review 2.  PET/Computed Tomography in Renal, Bladder, and Testicular Cancer.

Authors:  Kirsten Bouchelouche; Peter L Choyke
Journal:  PET Clin       Date:  2015-04-24

3.  [Functional imaging in bladder cancer].

Authors:  T Maurer; T Horn; A J Beer; M Eiber; J E Gschwend
Journal:  Urologe A       Date:  2013-04       Impact factor: 0.639

Review 4.  [Molecular multimodal hybrid imaging in prostate and bladder cancer].

Authors:  T Maurer; M Eiber; B J Krause
Journal:  Urologe A       Date:  2014-04       Impact factor: 0.639

5.  Halo artifacts of indwelling urinary catheter by inaccurate scatter correction in 18F-FDG PET/CT imaging: incidence, mechanism, and solutions.

Authors:  Keiichi Magota; Naoto Numata; Daiki Shinyama; Junya Katahata; Yamato Munakata; Piotr J Maniawski; Kentaro Kobayashi; Osamu Manabe; Kenji Hirata; Ukihide Tateishi; Kohsuke Kudo; Tohru Shiga
Journal:  EJNMMI Phys       Date:  2020-11-13

6.  Detecting primary bladder cancer using delayed (18)F-2-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography imaging after forced diuresis.

Authors:  Laura S Mertens; Annemarie Fioole-Bruining; Erik Vegt; Wouter V Vogel; Bas Wg van Rhijn; Simon Horenblas
Journal:  Indian J Nucl Med       Date:  2012-07

Review 7.  Current Staging Procedures in Urinary Bladder Cancer.

Authors:  Tobias Maurer; Thomas Horn; Matthias Heck; Jürgen E Gschwend; Matthias Eiber; Ambros J Beer
Journal:  Diagnostics (Basel)       Date:  2013-06-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.